BR112023000760A2 - Derivados de 7-(piperidin-1-il)-4h-pirimido[1,2-b]piridazin-4-ona como moduladores alostéricos positivos do receptor muscarínico m4 de acetilcolina - Google Patents
Derivados de 7-(piperidin-1-il)-4h-pirimido[1,2-b]piridazin-4-ona como moduladores alostéricos positivos do receptor muscarínico m4 de acetilcolinaInfo
- Publication number
- BR112023000760A2 BR112023000760A2 BR112023000760A BR112023000760A BR112023000760A2 BR 112023000760 A2 BR112023000760 A2 BR 112023000760A2 BR 112023000760 A BR112023000760 A BR 112023000760A BR 112023000760 A BR112023000760 A BR 112023000760A BR 112023000760 A2 BR112023000760 A2 BR 112023000760A2
- Authority
- BR
- Brazil
- Prior art keywords
- piperidin
- pyrimido
- pyridazin
- derivatives
- muscarinic acetylcholine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063052085P | 2020-07-15 | 2020-07-15 | |
| PCT/US2021/041836 WO2022015988A1 (en) | 2020-07-15 | 2021-07-15 | 7-(piperidin-1-yl)-4h-pyrimido[1,2-b]pyridazin-4-one derivatives as positive allosteric modulators of the muscarinic acetylcholine receptor m4 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023000760A2 true BR112023000760A2 (pt) | 2023-02-07 |
Family
ID=77051222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023000760A BR112023000760A2 (pt) | 2020-07-15 | 2021-07-15 | Derivados de 7-(piperidin-1-il)-4h-pirimido[1,2-b]piridazin-4-ona como moduladores alostéricos positivos do receptor muscarínico m4 de acetilcolina |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US12331055B2 (https=) |
| EP (1) | EP4182316A1 (https=) |
| JP (1) | JP7766946B2 (https=) |
| KR (1) | KR20230039701A (https=) |
| CN (1) | CN116209446B (https=) |
| AU (1) | AU2021308625A1 (https=) |
| BR (1) | BR112023000760A2 (https=) |
| CA (1) | CA3189217A1 (https=) |
| IL (1) | IL299758B2 (https=) |
| MX (1) | MX2023000580A (https=) |
| WO (1) | WO2022015988A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7766946B2 (ja) * | 2020-07-15 | 2025-11-11 | ヴァンダービルト ユニヴァーシティ | ムスカリン性アセチルコリン受容体ｍ４の陽性アロステリック調節因子としての７－（ピペリジン－１－イル）－４ｈ－ピリミド［１，２－ｂ］ピリダジン－４－オン誘導体 |
| WO2023114224A1 (en) | 2021-12-13 | 2023-06-22 | Sage Therapeutics, Inc. | Combination of muscarinic receptor positive modulators and nmda positive allosteric modulators |
| WO2023141511A1 (en) * | 2022-01-19 | 2023-07-27 | Vanderbilt University | Positive allosteric modulators of the muscarinic acetylcholine receptor m4 |
| WO2024117795A1 (ko) | 2022-12-02 | 2024-06-06 | 주식회사 엘지에너지솔루션 | 배터리 팩 및 그의 제조 방법 |
| AU2024259614A1 (en) | 2023-04-18 | 2025-10-02 | Vanderbilt University | Thiazolopyridine derivatives as positive allosteric modulators of the muscarinic acetylcholine receptor m4 |
| EP4731624A1 (en) * | 2023-06-22 | 2026-04-29 | Vanderbilt University | Positive modulators of the muscarinic acetylcholine receptor m4 |
| WO2025122733A1 (en) | 2023-12-07 | 2025-06-12 | Neumora Therapeutics, Inc. | Crystalline forms of 7-((2r,4s)-4-((2,3-dihydrobenzo[b][1,4] dioxin-6-yl-2,2,3,3-d4)oxy)-2-methylpiperidin-1-yl)-8-methyl-4h-pyrimido[1,2-b]pyridazin -4-one |
| WO2026047494A1 (en) | 2024-08-26 | 2026-03-05 | Suven Life Sciences Limited | 2-AMINO-PYRIMIDINE DERIVATIVES AS MUSCARINIC M4 RECEPTOR POSITIVE ALLOSTERIC MODULATORS (M4 PAMs) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9156833B2 (en) * | 2012-07-16 | 2015-10-13 | Barry University, Inc. | Bitopic muscarinic agonists and antagonists and methods of synthesis and use thereof |
| JP6478923B2 (ja) * | 2013-02-07 | 2019-03-06 | ヘプタレス セラピューティクス リミテッドＨｅｐｔａｒｅｓ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ | ムスカリンｍ４受容体アゴニストとしてのピペリジン−１−イル及びアゼピン−１−イルカルボキシレート |
| TW201726675A (zh) | 2015-12-23 | 2017-08-01 | 默沙東藥廠 | M4毒蕈鹼乙醯膽鹼受體之異位調節劑6,7-二氫-5h-吡咯并[3,4-b]吡啶-5-酮 |
| WO2017107087A1 (en) * | 2015-12-23 | 2017-06-29 | Merck Sharp & Dohme Corp. | 6, 7-dihydro-5h-pyrrolo [3, 4-b] pyridin-5-oneallosteric modulators of the m4 muscarinic acetylcholine receptor |
| US10961253B2 (en) | 2016-11-07 | 2021-03-30 | Vanderbilt University | Positive allosteric modulators of the muscarinic acetylcholine receptor M4 |
| WO2018112843A1 (en) * | 2016-12-22 | 2018-06-28 | Merck Sharp & Dohme Corp. | Heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor |
| WO2018112842A1 (en) * | 2016-12-22 | 2018-06-28 | Merck Sharp & Dohme Corp. | 6,6-fused heteroaryl piperidine ether allosteric modulators of m4 muscarinic acetylcholine receptor |
| WO2018112840A1 (en) | 2016-12-22 | 2018-06-28 | Merck Sharp & Dohme Corp. | 6, 5-fused heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor |
| WO2019000238A1 (en) * | 2017-06-27 | 2019-01-03 | Merck Sharp & Dohme Corp. | 5- (PYRIDIN-3-YL) OXAZOLE ALLOSTERIC MODULATORS OF M4 ACETYLCHOLINE MUSCARINIC RECEPTOR |
| JP7766946B2 (ja) * | 2020-07-15 | 2025-11-11 | ヴァンダービルト ユニヴァーシティ | ムスカリン性アセチルコリン受容体ｍ４の陽性アロステリック調節因子としての７－（ピペリジン－１－イル）－４ｈ－ピリミド［１，２－ｂ］ピリダジン－４－オン誘導体 |
-
2021
- 2021-07-15 JP JP2023502593A patent/JP7766946B2/ja active Active
- 2021-07-15 WO PCT/US2021/041836 patent/WO2022015988A1/en not_active Ceased
- 2021-07-15 CN CN202180061237.9A patent/CN116209446B/zh active Active
- 2021-07-15 KR KR1020237005195A patent/KR20230039701A/ko not_active Withdrawn
- 2021-07-15 IL IL299758A patent/IL299758B2/en unknown
- 2021-07-15 EP EP21746304.1A patent/EP4182316A1/en active Pending
- 2021-07-15 US US18/005,301 patent/US12331055B2/en active Active
- 2021-07-15 AU AU2021308625A patent/AU2021308625A1/en active Pending
- 2021-07-15 CA CA3189217A patent/CA3189217A1/en active Pending
- 2021-07-15 MX MX2023000580A patent/MX2023000580A/es unknown
- 2021-07-15 BR BR112023000760A patent/BR112023000760A2/pt unknown
-
2023
- 2023-03-22 US US18/187,868 patent/US11884676B2/en active Active
-
2025
- 2025-05-09 US US19/203,407 patent/US20250263417A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP7766946B2 (ja) | 2025-11-11 |
| AU2021308625A1 (en) | 2023-02-09 |
| CN116209446A (zh) | 2023-06-02 |
| CA3189217A1 (en) | 2022-01-20 |
| US20230257381A1 (en) | 2023-08-17 |
| US20250263417A1 (en) | 2025-08-21 |
| EP4182316A1 (en) | 2023-05-24 |
| IL299758B2 (en) | 2026-04-01 |
| IL299758A (en) | 2023-03-01 |
| CN116209446B (zh) | 2025-05-13 |
| IL299758B1 (en) | 2025-12-01 |
| WO2022015988A1 (en) | 2022-01-20 |
| JP2023534803A (ja) | 2023-08-14 |
| US20230286991A1 (en) | 2023-09-14 |
| KR20230039701A (ko) | 2023-03-21 |
| US12331055B2 (en) | 2025-06-17 |
| MX2023000580A (es) | 2023-02-13 |
| US11884676B2 (en) | 2024-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112023000760A2 (pt) | Derivados de 7-(piperidin-1-il)-4h-pirimido[1,2-b]piridazin-4-ona como moduladores alostéricos positivos do receptor muscarínico m4 de acetilcolina | |
| BRPI0614168A2 (pt) | Composto ou um sal, hidrato, solvato, isoforma, tautômero, isômero óptico farmaceuticamente aceitável ou uma combinação dos mesmos, composição farmacêutica, método para o tratamento ou prevenção de distúrbios neurológicos e psquiátricos, uso de um composto, e, processo para a preparação de um composto | |
| NI201800141A (es) | Moduladores alostéricos positivos del receptor muscarínico de acetilcolina m4 | |
| GT200000107A (es) | Procedimiento para la obtencion de "compuestos de indazol y composiciones farmaceuticas para inhibir las quinasas deproteina y metodos para su uso". | |
| PE20060775A1 (es) | Derivados de pirrolidilo de compuestos heteroaromaticos como inhibidores de fosfodiesterasa | |
| BRPI0809998B8 (pt) | composto de imidazo[1,2-a] piridina como inibidores do receptor tirosina quinase, seus usos, seus processos de preparação e composições farmacêuticas | |
| BR112013001088A2 (pt) | "derivados substituídos como inibidores a quinase de imidazoquinolina" | |
| US10316025B2 (en) | Substituted piperazine compounds and methods of use and use thereof | |
| DE69922823D1 (de) | 6-SUBSTITUIERTE PYRAZOLO(3,4-d)PYRIMIDIN-4-ONE VERWENDBAR ALS CYCLIN-ABHÄNGIGE KINASEHEMMER | |
| AR035374A1 (es) | Un derivado de fenilacetamido-pirazol, su uso, un procedimiento para su preparacion, una composicion farmaceutica que lo comprende, un kit que comprende dicho derivado o composicion, un metodo para tratar desordenes proliferativos celularaes asociados con una actividad quinasa dependiente de ciclo c | |
| AR064608A1 (es) | Derivados de pirazolo-quinazolina sustituidos, composiciones farmaceuticas que los contienen. proceso para su preparacion y uso de los mismos como agentes anticancer. | |
| US11878972B2 (en) | Treatment of neurological disorders | |
| BR112018013882A2 (pt) | moduladores alostéricos positivos do receptor muscarínico de acetilcolina m4 | |
| BR112018013763A2 (pt) | moduladores alostéricos positivos do receptor muscarínico de acetilclona m4 | |
| UA86617C2 (en) | 2-(1-AZA-BICYCLO[2.2.2]OCT-3-YL)-2,3-DIHYDROISOINDOL-l-ONE/5,6-DIHYDRO-FURO[2,3-c]PYRROL-4-ONE DERIVATIVES AS LIGANDS FOR ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR | |
| AR111176A1 (es) | Derivados pirazol[1,5-a]pirimidina sustituidos con alicíclicos farmacológicamente activos | |
| BR112018013879A2 (pt) | moduladores alostéricos positivos do receptor muscarínico de acetilcolina m4 | |
| AU2024270624A1 (en) | Treatment of skin disorders | |
| EA202190322A1 (ru) | ИМИДАЗО[1,2-b]ПИРИДАЗИНОВЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ TRK | |
| US11932639B2 (en) | Fused ring heteroaryl compounds as ALK4/5 inhibitors | |
| BR112019024804A2 (pt) | compostos bicíclicos 5,6-fundidos e composições para o tratamento de doenças parasíticas | |
| JP7118509B2 (ja) | 皮膚病変の治療 | |
| CO2023012333A2 (es) | Profármacos de compuestos de pde10 | |
| CL2025002917A1 (es) | Formulaciones de pde10a de liberación controlada. | |
| BR112018073579B1 (pt) | Uso de inibidores específicos de mtor ou inibidores duplos de pi3k/mtor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] |